- 2024 Ovarian Cancer Program
- Basic Science
- Podcast Series
- Targeted Therapies in Lung Cancer 2023
- ASCO® 2023
- Lung Cancer OncTalk
- Blood Cancer OncTalk
- 2022 Melanoma Video Library
- OncTalk 2022
- ASCO Lung Review 2022
- ASCO and ESMO Lung Recap
- 2021 Targeted Therapies Patient Forum
- COVID-19
- Lung
- Hematologic Oncology
- Head and Neck
- Brain
- Palliative
- Genitourinary
- General
- Breast
Playback speed
10 seconds
NSCLC Q&A: After CRT, What Is Recommended for 2L Treatment and Timing in Stage 3 ROS1+ Lung Cancer?
28 views
April 20, 2022
Comments 0
Login to view comments.
Click here to Login
2021 Targeted Therapies Patient Forum